Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials

Journal of Hypertension
Costas ThomopoulosAlberto Zanchetti

Abstract

Relative effectiveness of blood pressure (BP)-lowering treatment on various outcomes was evaluated by meta-analyses restricted to randomized controlled trials (RCTs) measuring all major outcomes, and the question whether BP lowering and each class of antihypertensive agents prevent new-onset heart failure by meta-analyses limited to RCTs excluding baseline heart failure from randomization. Source of these meta-analyses are our databases of BP-lowering RCTs vs placebo or less-active treatment, and head-to-head comparisons of different antihypertensive classes. Risk ratios (RRs) and 95% confidence intervals of seven outcomes were calculated by a random-effects model. The relationships of outcome reductions to BP differences were investigated by meta-regressions. First, 35 BP-lowering RCTs measured all outcomes, and heart failure [RR 0.63 (0.52-0.75)] and stroke [RR 0.58 (0.49-0.68)] were the outcomes most effectively prevented. Second, heart failure and stroke reductions were significantly related to SBP, DBP and pulse pressure reductions. Third, in 18 BP-lowering RCTs excluding baseline heart failure from recruitment, heart failure reduction ('new-onset' heart failure) [RR 0.58 (0.44-0.75)] was very similar to that in the entire...Continue Reading

References

Jan 1, 1977·Circulation Research·V ElharrarD P Zipes
Jan 1, 1989·Stroke; a Journal of Cerebral Circulation·H M PerryJ A Schoenberger
Nov 1, 1986·British Medical Journal·J Coope, T S Warrender
Oct 19, 1972·The New England Journal of Medicine·W B KannelM Feinleib
Jul 22, 1974·JAMA : the Journal of the American Medical Association
Mar 1, 1966·Journal of Chronic Diseases·F W Wolff, R D Lindeman
Nov 1, 1980·The American Journal of Medicine·A Helgeland
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Nov 2, 2001·Diabetes Research and Clinical Practice·S Baba, UNKNOWN J-MIND Study Group
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Feb 14, 2003·The New England Journal of Medicine·Lindon M H WingUNKNOWN Second Australian National Blood Pressure Study Group
Apr 24, 2003·JAMA : the Journal of the American Medical Association·Henry R BlackUNKNOWN CONVINCE Research Group
Jul 24, 2003·Blood Pressure·Ettore MalaccoUNKNOWN Shell Investigators
Apr 15, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yoshiki YuiUNKNOWN Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group
Sep 8, 2004·Lancet·Philip A Poole-WilsonUNKNOWN Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators
Nov 2, 2004·The New England Journal of Medicine·Anthony H BarnettUNKNOWN Diabetics Exposed to Telmisartan and Enalapril Study Group
Nov 9, 2004·The New England Journal of Medicine·Eugene BraunwaldUNKNOWN PEACE Trial Investigators
Nov 13, 2004·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN CAMELOT Investigators
Sep 6, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hiromichi SuzukiUNKNOWN Efficacy of Candesartan on Outcome in Saitama Trial (E-COST) Group
Sep 15, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tsukasa NakamuraUNKNOWN Efficacy of Candesartan on Outcome in Saitama Trial Group
Jan 4, 2008·Hypertension·Toshio OgiharaUNKNOWN Candesartan Antihypertensive Survival Evaluation in Japan Trial Group
Apr 2, 2008·The New England Journal of Medicine·Nigel S BeckettUNKNOWN HYVET Study Group
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Apr 10, 2008·JAMA : the Journal of the American Medical Association·Barbara V HowardJianhui Zhu

❮ Previous
Next ❯

Citations

Aug 9, 2016·International Journal of Cardiology·Hojung LeeJungtae Leem
Mar 6, 2016·Therapeutic Advances in Cardiovascular Disease·Rainer Düsing
Dec 7, 2017·Journal of Hypertension·Costas Thomopoulos, Helena Michalopoulou
Apr 19, 2018·The Cochrane Database of Systematic Reviews·James M WrightRupam Gill
Aug 17, 2017·The Cochrane Database of Systematic Reviews·Vijaya M MusiniJames M Wright
Jun 18, 2017·Journal of the American Heart Association·Antoine H ChaanineMargaret M Redfield
Jun 6, 2019·The Cochrane Database of Systematic Reviews·Vijaya M MusiniJames M Wright
Aug 23, 2019·Revista brasileira de enfermagem·Fernando Hiago da Silva DuarteRichardson Augusto Rosendo da Silva
Sep 13, 2019·Heart Failure Reviews·Nicola Riccardo PuglieseStefano Taddei
Oct 26, 2018·Circulation Research·Suzanne OparilJackson T Wright
Jan 20, 2019·Current Hypertension Reports·Sergio H R Ramalho, Amil M Shah
Sep 8, 2017·Current Cardiology Reports·Jamael HoosainShelley Hankins
Jan 20, 2019·Current Hypertension Reports·Bharathi UpadhyaDalane W Kitzman
Jan 8, 2020·Clinical Hypertension·Gyu Chul Oh, Hyun-Jai Cho
Sep 4, 2020·Current Hypertension Reports·Harry E HicklinBharathi Upadhya
Aug 31, 2018·European Heart Journal·Bryan WilliamsUNKNOWN ESC Scientific Document Group
Mar 30, 2017·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Maria Lorenza MuiesanMassimo Salvetti
Mar 13, 2019·Lancet·Patrick RossignolFaiez Zannad
Apr 7, 2021·European Heart Journal. Cardiovascular Pharmacotherapy·João Pedro FerreiraFaiez Zannad
Jun 5, 2021·Journal of the American College of Cardiology·Sammy Elmariah, Nilay K Patel
Apr 2, 2017·Circulation. Heart Failure·Bharathi UpadhyaUNKNOWN SPRINT Research Group

❮ Previous
Next ❯

Software Mentioned

ALLHAT
Comprehensive Meta Analysis
INSIGHT
ACCOMPLISH

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.